Marshall Wace LLP Invests $158,000 in ProQR Therapeutics (NASDAQ:PRQR)
Marshall Wace LLP acquired a new stake in shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 59,515 shares of the biopharmaceutical company’s stock, valued at approximately $158,000. Marshall Wace LLP owned 0.07% of ProQR Therapeutics […]
Marshall Wace LLP acquired a new stake in shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 59,515 shares of the biopharmaceutical company’s stock, valued at approximately $158,000. Marshall Wace LLP owned 0.07% of ProQR Therapeutics […]
